Related Experiment Video
Updated: Jul 6, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Evidence for no global effect of metabolic syndrome per se on early hypertensive sequelae
Costas Tsioufis1, Dimitris Tsiachris, Kyriakos Dimitriadis
1Department of Cardiology, Hippokration Hospital, Athens, Greece. ktsioufis@hippocratio.gr
Insights
Metabolic syndrome (MS) in hypertensive patients does not worsen cardiac structure or arterial stiffness beyond blood pressure effects. However, MS independently predicts glomerular damage, indicated by increased albumin-to-creatinine ratio.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Diseases
Background:
- Essential hypertension is a major risk factor for cardiovascular and renal damage.
- Metabolic syndrome (MS) is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
- The impact of MS on target organ damage in hypertensive individuals requires further elucidation.
Purpose of the Study:
- To assess the impact of metabolic syndrome (MS) and its components on cardiovascular and renal damage markers in essential hypertensive patients.
- To determine if MS independently predicts organ damage beyond the effects of blood pressure.
Main Methods:
- Analysis of 651 untreated, non-diabetic hypertensive patients from the 3H Study.
- Assessment of left ventricular mass (indexed for body surface area and height), diastolic function (conventional and tissue Doppler imaging), arterial stiffness (carotid-femoral pulse wave velocity), and microalbuminuria (albumin-to-creatinine ratio).
- Statistical analysis including multiple regression to identify independent predictors of organ damage.
Main Results:
- Metabolic syndrome was present in 30.9% of hypertensive patients.
- Hypertensives with MS showed a higher prevalence of microalbuminuria and increased albumin-to-creatinine ratio.
- Left ventricular mass indexed for height was higher in MS patients, but cardiac adaptations and arterial stiffness were similar between groups with and without MS, suggesting haemodynamic load as the primary driver.
- MS was an independent predictor of increased albumin-to-creatinine ratio and microalbuminuria, indicating renal glomerular impact.
Conclusions:
- Metabolic syndrome does not exacerbate cardiac adaptations or aortic stiffness in hypertension beyond the effects of haemodynamic load.
- The detrimental effect of MS in hypertensive individuals is primarily confined to the renal glomerulus.
- Blood pressure components significantly influenced all studied indices of organ damage.
Objective:
In the present study we assessed the impact of metabolic syndrome (MS) and its components on markers of cardiovascular and renal damage in a population of essential hypertensives.
Methods:
A total of 651 consecutive, untreated and non-diabetic hypertensives (age 54 +/- 12 years, 340 males) who were included in the 3H Study, an ongoing registry of hypertension-related target organ damage, were considered for analysis. Left ventricular mass was indexed both for body surface area (LVMBSA) and for height2.7 (LVMheight2.7). Diastolic function was estimated by means of both conventional and tissue Doppler imaging (TDI) methods. Arterial stiffness was evaluated on the basis of carotid to femoral pulse wave velocity (c-f PWV) and microalbuminuria (MA) as albumin to creatinine ratio (ACR) 22-300 mg/g in men and 31-300 mg/g in women in two non-consecutive morning spot urine samples.
Results:
MS (Adult Treatment Panel III criteria) was present in 201 hypertensives (30.9%). Hypertensives with MS had increased logACR (by 10%, P = 0.01) and higher prevalence of MA (17 versus 8%, P < 0.001). Both groups exhibited similar values of LVMBSA, transmitral and TDI-derived indexes and c-f PWV (NS for all) while LVMheight2.7 was significantly higher in hypertensives with MS (by 2.6 g/m2.7, P = 0.023). Multiple regression analysis revealed that MS was an independent predictor only of logACR (beta = 0.110, P = 0.007) and MA (odds ratio = 2.577, P < 0.001), while components of blood pressure affected all studied indices of organ damage.
Conclusions:
MS per se does not deteriorate cardiac adaptations and aortic stiffness beyond haemodynamic load in hypertension. The MS-related unfavourable effect is limited to the level of the glomerulus.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Coronary Artery Disease I: Introduction
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...